INTRODUCTION
============

Aquaculture is among the fastest growing businesses in the food production industry ([@b13-molce-41-6-495]), and streptococcal infections have caused significant economic losses in the aquaculture industry ([@b7-molce-41-6-495]; [@b68-molce-41-6-495]).

Various bacterial agents cause streptococcosis; *Streptococcus parauberis, Streptococcus iniae*, *Streptococcus agalactiae*, and *Streptococcus dysgalactiae* are the prominent species regardless of geographical region ([@b4-molce-41-6-495]; [@b52-molce-41-6-495]; [@b53-molce-41-6-495]; [@b68-molce-41-6-495]; [@b70-molce-41-6-495]). Fish are an important food source, but have always been at risk of acquiring *Streptococcus* infections owing to continuous exposure and ubiquitous global presence of various bacterial strains and species. Currently, there are several methods for detecting and identifying *Streptococcus* spp., depending upon the phenotypic characteristics, species, and strains of bacteria.

Control of streptococcus infection mainly relies on the use of antimicrobial compounds, vaccinations, and environmental strategies ([@b22-molce-41-6-495]; [@b25-molce-41-6-495]; [@b36-molce-41-6-495]; [@b65-molce-41-6-495]; [@b73-molce-41-6-495]), of which vaccines and antimicrobial compounds have been ineffective for various reasons ([@b4-molce-41-6-495]; [@b56-molce-41-6-495]; [@b64-molce-41-6-495]; [@b68-molce-41-6-495]). Environmental strategies have been used to control fish infections in their natural and artificial habitats by several methods ([@b37-molce-41-6-495]). In this review, we discuss the current status and challenges in diagnosis, pathogenesis, and control of streptococcal disease in fish and we suggest effective control strategies.

WORLDWIDE DISTRIBUTION AND RISK FACTORS FOR STREPTOCOCCAL DISEASE
=================================================================

Streptococcal disease occurs in all continents (Americas, Asia, Europe, Africa, and Australia) ([Table 1](#t1-molce-41-6-495){ref-type="table"} and [Fig. 1](#f1-molce-41-6-495){ref-type="fig"}). Thousands of *Streptococcus* species (*S. parauberis, S. iniae, S. agalactiae, Lactococcus garvieae, S. dysgalactiae,* and *Vagococcus salmoninarum*) have been reported in different parts of the world ([@b2-molce-41-6-495]; [@b4-molce-41-6-495]; [@b8-molce-41-6-495]; [@b18-molce-41-6-495]; [@b21-molce-41-6-495]; [@b27-molce-41-6-495]; [@b43-molce-41-6-495]; [@b53-molce-41-6-495]; [@b57-molce-41-6-495]; [@b60-molce-41-6-495]) ([Fig. 1](#f1-molce-41-6-495){ref-type="fig"}). Streptococcosis is a multifactorial disease in fish, depending on host variety, age, immune status, type of pathogen (species and strain), and environmental conditions ([@b35-molce-41-6-495]; [@b59-molce-41-6-495]; [@b70-molce-41-6-495]).

CURRENT CHALLENGES IN STREPTOCOCCOSIS DIAGNOSIS
===============================================

Currently, the immediate and inexpensive diagnosis of streptococcosis in infected fish is difficult as fish exhibit similar clinical symptoms regardless of the etiological agent ([Table 1](#t1-molce-41-6-495){ref-type="table"} and [Fig. 1](#f1-molce-41-6-495){ref-type="fig"}) ([@b8-molce-41-6-495]; [@b50-molce-41-6-495]). Various issues of diagnosis are discussed below.

Clinical phenotype is the primary signature of bacterial infections that depends on various factors, so it is difficult to understand the precise cause of infection. A study of tilapia fish showed that clinical phenotypes and degree of lesions depend on several factors such as *S. agalactiae* strain variations, their infectious dose, water conditions, temperature, and handling procedures ([@b21-molce-41-6-495]). Due to the complexity of bacteria and their interrelations, microbiologists occasionally misidentify or cannot identify isolates ([@b42-molce-41-6-495]). Asymptomatic fish serve as a pathogen reservoir and pose challenges for correct identification due to the absence of clinical signs ([@b16-molce-41-6-495]). Presently, diagnosis of subclinical infections in fish is a major concern.

Bacterial identification methods based on culture, morphology, or biochemical reactions are time- and resource-consuming. Some pathogen databases (RAPID Strep strip, VITEX systems, API 20E STREP, Rapid Strep 32 and ATB Expression System) are incomplete or incorrect, and result in improper identification of bacteria ([@b29-molce-41-6-495]; [@b32-molce-41-6-495]; [@b42-molce-41-6-495]). Additionally, other challenges for accurate identification include the mixed nature of the aquaculture environment, low numbers of biological samples, or unknown tissue location in carriers ([@b40-molce-41-6-495]). Identification of *S. agalactiae* based on biochemical features (i.e. capacity to hydrolyze hippurate) or phenotypic characteristics (acidification of tagatose, ribose, and sucrose) are not effective due to high levels of biochemical heterogeneity among strains ([@b59-molce-41-6-495]).

Molecular methods are based on several candidate genes ([Table 2](#t2-molce-41-6-495){ref-type="table"}), that have been well characterized for diversity, including 16S rRNA, heat-shock genes (*groESL*), and tRNA gene intergenic spacer regions (ITSs) ([@b24-molce-41-6-495]; [@b67-molce-41-6-495]). Comparative studies have discussed various methodologies and found molecular methods to be most effective for bacterial identification ([@b14-molce-41-6-495]). *S. dysgalactiae* (GCSD) was recently identified as a fish-specific pathogen based on 16S rRNA, *sodA*, and *tuf* gene sequence analysis ([@b2-molce-41-6-495]). Phenotypic criteria failed to differentiate between genealogically distinct *L. garvieae* and *Lactococcus lactis* strains*,* so correct identification was determined by molecular methods ([@b41-molce-41-6-495]; [@b70-molce-41-6-495]). However, some limitations are associated with diversity experiments. For example, closely related species could not be distinguished by 16S rRNA in a study by the Mitis group at the NHS ([@b54-molce-41-6-495]). Moreover, the taxonomic position of several aquatic isolates is still unclear ([@b7-molce-41-6-495]).

Another molecular method, multilocus sequence typing (MLST; analyses of multiple genetic loci or housekeeping genes) is considered the "gold standard" of typing for many bacterial species ([@b46-molce-41-6-495]; [@b39-molce-41-6-495]). However, insufficient resolution among very closely related bacteria can be a problem ([@b3-molce-41-6-495]).

CURRENT CHALLENGES IN ELUCIDATING STREPTOCOCCOSIS PATHOGENESIS
==============================================================

The pathogenesis of streptococcosis depends upon several factors that vary with fish species and bacterial species and isolates. Further details of virulence and pathogenicity of streptococcosis are given below.

Genetic virulence depends on several factors; for example, *S. iniae* virulence is associated with a unique genetic profile ([@b33-molce-41-6-495]). Comparison of 17 geographically different strains of *L. garvieae* based on genetic homogeneity vs. serological data showed that pathogen diversity is related to virulence factors ([@b9-molce-41-6-495]). Another study showed that the lactococcal bacterial population presented a clonal structure in endemic regions, while in sporadic regions, it displayed a high genetic heterogeneity ([@b31-molce-41-6-495]). Virulence experiments have shown that capsulated *L. garvieae* strains are more virulent than non-capsulated strains in rainbow trout ([@b10-molce-41-6-495]). Virulence varies with bacterial isolates within the same species in *S. dysgalactiae* ([@b1-molce-41-6-495]). Currently, the potential for *Streptococcus* species to cross interspecies barriers and cause disease in other hosts is poorly understood.

Many streptococcal species are multi-host pathogens. Humans constantly face the risk of infection due to close interactions with the fish industry ([@b1-molce-41-6-495]). *S. iniae, S. agalactiae, L. garvieae*, and *S. dysgalactiae* are human pathogens, and thus are a major threat to public health. *S. iniae* can cause bacteremic cellulitis, septic arthritis, meningitis, and endocarditis ([@b4-molce-41-6-495]; [@b5-molce-41-6-495]; [@b32-molce-41-6-495]; [@b42-molce-41-6-495]; [@b72-molce-41-6-495]), while *S. agalactiae* can cause meningitis and pneumonia in humans ([@b15-molce-41-6-495]; [@b38-molce-41-6-495]).

CURRENT CHALLENGES FOR CONTROLLING STREPTOCOCCOSIS
==================================================

Disease control using antimicrobials, vaccination, and environmental strategies are used extensively; however, some are associated with various downstream challenges that are mentioned in [Fig. 2](#f2-molce-41-6-495){ref-type="fig"} and discussed in detail below.

Streptococcal diseases in fish initially affect the skin, fins, gills, and external organs. Thus, controlling infections externally through liquid disinfecting agents that can dissolve in water very easily (copper sulfate and formalin) are a good option, however, these agents cause hazardous environmental side effects.

Antibiotic resistance genes are frequently transferred among bacterial species, leading to resistant *Streptococcus* isolates and imposing a lasting risk to public health ([@b56-molce-41-6-495]). The selection for resistance among dense populations and drug residues in farmed fish are major concerns associated with human health; moreover, elimination of therapeutic compounds depends on several factors that can affect the fish metabolic rates such as dose rate, route of administration, water temperature, and type of isolate ([@b4-molce-41-6-495]). *V. salmoninarum* is resistant to most antibiotics registered for aquaculture use in the European Union ([@b60-molce-41-6-495]). Studies show that the long-term use of antibiotics in olive flounder fish may have generated a higher degree of antibiotic resistance in *S. parauberis* than in *S. iniae* ([@b56-molce-41-6-495]). Antibiotic sensitivity and resistance vary by geographical region in *L.* garvieae ([@b27-molce-41-6-495]; [@b59-molce-41-6-495]; [@b70-molce-41-6-495]).

The capacity of bacteria to bypass any phagocyte activity and oxidative killing of host cells is a very important step utilized for vaccination strategies ([@b17-molce-41-6-495]). Pathogenicity of streptococcal bacteria depends on their capability to survive in host immune cells. The bacteria induce internal apoptosis while avoiding killing host cells to establish infections ([@b73-molce-41-6-495]; [@b76-molce-41-6-495]). The pathogenesis of *S. iniae* infection is still not fully understood as it depends upon various virulence factors and multistep processes ([@b76-molce-41-6-495]). Many wide spread vaccination programs have been unsuccessful for various reasons such as regional or short-lived effects due to limited knowledge of immunity and virulence factors in fish ([@b4-molce-41-6-495]). One of the recent challenges in streptococcal disease is the histological infection of various organs (liver, spleen, kidney, brain, etc.). Thus, vaccination methods will not be effective unless they provoke a systemic immune response ([@b43-molce-41-6-495]). Additionally, complete knowledge of molecular and cellular processes involved in disease progression is crucial to understand various downstream complications. Vaccine preparation and optimizations solely depend on an understanding of many biological processes such as bacterial morphology, biochemical assays (serotype), pathogenicity (virulence), and immunogenicity. However, understanding molecular and cellular processes for long-term protection and cost effectiveness will be crucial to promote the widespread use of vaccines.

The environment can modulate the innate immune system in fish, so any intensive culture systems immediately make fish susceptible to infection and provide a further source for the spread of infection ([@b45-molce-41-6-495]). Studies show that increased fish density and other stress factors can elicit harmful effects in fish ([@b30-molce-41-6-495]; [@b63-molce-41-6-495]; [@b64-molce-41-6-495]). A system for improving water quality and monitoring fish health is another parameter that can decrease the chances of infection, as deteriorating water quality promotes the rapid spread of bacteria and mortality ([@b30-molce-41-6-495]). Various additional strategies, such as reducing fish density by using effective physical barriers (netting), and removing moribund fish are also considered to be effective steps ([@b63-molce-41-6-495]; [@b64-molce-41-6-495]).

EFFECTIVE CONTROL OF *STREPTOCOCCUS*
====================================

Effective control systems can be established through coordination and complete knowledge of the fishery industry, fish molecular and cellular biology, ecological conditions, bacterial molecular and cellular biology, and appropriate management. However, based on various studies, it is also clear that due to the unavailability of any effective and universal vaccines or antibiotics for fish diseases, environmental protective measures may be the best strategies for controlling streptococcal disease ([Fig. 3](#f3-molce-41-6-495){ref-type="fig"}).

Environmental control is most ideal as it is inexpensive, easily monitored, and is not associated with any side effects ([Figs. 2](#f2-molce-41-6-495){ref-type="fig"} and [3](#f3-molce-41-6-495){ref-type="fig"}). Here, we briefly discuss the important parameters that should be addressed for effective environmental control.

Studies have suggested that virulence factors play an important role in pathogenesis and disease ([@b11-molce-41-6-495]; [@b58-molce-41-6-495]). Thus, basic and advanced research at the cellular level can provide more knowledge of biological processes involved in fish resistance against streptococcal diseases. These studies should focus on understanding innate and adaptive responses through cellular (macrophages, T cell and B cell markers) and humoral (various immunoglobulin classes, complement factors, cytokines) pathways. Studies have shown that several factors are involved in the regulation of Group B streptococci (GBS) disease pathogenesis, including pore-forming toxins and several adherence and immune evasion factors, which are reviewed in detail in [Table 1](#t1-molce-41-6-495){ref-type="table"} of [@b58-molce-41-6-495]. Additionally, signal transduction systems (STSs) are also important drug targets for effective disease control (Barrett et al., 1998; [@b58-molce-41-6-495]). Several *S. agalactiae* factors, such as polysaccharide capsule, hemolysin, superoxide dismutase, and D-alanylated lipoteichoic acid, hold major importance for virulence (Lindahl et al., 2005). Various surface proteins of *S. agalactiae* participate in important functions during disease progression, thus they are also considered important vaccine candidates ([@b19-molce-41-6-495]; Lindahl et al., 2005).

Many immunostimulants can stimulate pathogen-associated molecular patterns (PAMPS), which are part of fish immune systems as pathogen recognition receptors (PRRs) and participate in maintaining innate immune protection for fish ([@b23-molce-41-6-495]).

Recently, dietary intake of bacterial components, polysaccharides, animal-derived nutrients, plant extracts, nutritional factors, and cytokines has been reported to be an effective method for immunostimulation in fish ([@b61-molce-41-6-495]; [@b71-molce-41-6-495]). Further advanced cellular studies of immunostimulants are required for understanding various downstream cellular activities such as hemotaxis, respiratory burst, phagocytosis, and lysozymes to establish the most effective stimulants for fish. Additionally, the development of a range of assays such as immunohistochemistry, immunocytochemistry, flow-cytometry, and gene expression technology combined with *in vivo* challenge studies can improve our understanding in a more advanced way and help design effective vaccines or therapeutic agents for fish diseases.

Knowledge of genetic virulence factors is important for understanding disease mechanisms and progression. Unfortunately, studies have been limited to rat and mouse models for various streptococci so far. The molecular basis of virulence was described in detail by Bennedsen et al. in 2011 ([@b12-molce-41-6-495]; [@b66-molce-41-6-495]). Virulence factors vary with the streptococci strain and host since host/external environments are also responsible for variable expression of virulent genes.

Some important genetic virulence factors like polysaccharide capsules gene (*cps*), invasion associated gene (*iag*), surface immunogenic protein (*sip*), C5a peptidase (*scp*), serine protease (*csp*), and many surface proteins have been studied extensively in various streptococcus species ([Table 2](#t2-molce-41-6-495){ref-type="table"}) ([@b44-molce-41-6-495]; [@b58-molce-41-6-495]; [@b66-molce-41-6-495]). Additional factors regulating expression of virulence genes, like STSs, membrane associated sensor histidine kinase (HK), and toxins can also be targeted for disease pathogenesis ([@b44-molce-41-6-495]; [@b58-molce-41-6-495]; [@b66-molce-41-6-495]). Genomic comparison of virulent and non-virulent *S. agalactiae* showed differences among isolates that infect fish, humans, cattle, and sea mammals; moreover, several host (fish) genes translate proteins that are responsible for adaptation in the aquatic environment ([@b26-molce-41-6-495]). Isolates from one host are not necessarily pathogenic to other hosts or to different strains of the same fish ([@b55-molce-41-6-495]).

The recent introduction of 'next-generation' sequencing technology has brought a revolution in bacterial research as many bacterial genomes and antimicrobial resistance and virulence genes are available for analysis ([@b20-molce-41-6-495]; [@b51-molce-41-6-495]; [@b47-molce-41-6-495]). Currently, the use of whole-genome sequencing (WGS) for typing any bacterial agent is possible in a cost effective and timely manner ([@b51-molce-41-6-495]). The Genus *Streptococcus* comprises diverse bacterial species that emerged through the course of evolution with various known and unknown evolutionarily important factors distributed worldwide. These evolutionary genetic, environmental, biochemical, and physiological factors shape streptococcus at the phenotype and genotype levels. Among them, genetic factors such as genomic variation through addition, reduction, and gene transfer play a crucial role for appropriately measuring exponential growth of diversified streptococcus genomes. Therefore, a future study should examine geographically distributed strains as they develop specific variations under different environmental conditions, which can affect their functional properties, and ultimately their virulence.

Choosing conserved genes (e.g., *16S rRNA, ITS*) over other genes relies on the fact that any variation observed can be directly correlated to the physiology and virulence properties of an organism ([@b53-molce-41-6-495]) and for understanding evolutionary relationships and disease epidemiology ([@b28-molce-41-6-495]; [@b62-molce-41-6-495]; [@b74-molce-41-6-495]). Additionally, a well-defined 16S rRNA and ITS database for sequence comparisons suggested that molecular techniques are appropriate for both taxonomic and identification purposes ([@b48-molce-41-6-495]; [@b49-molce-41-6-495]; [@b75-molce-41-6-495]). Advanced genomics refers to high-throughput genetic technologies (based on DNA or RNA nucleotides) and their evaluation through comparative, functional, or environmental parameters ([@b34-molce-41-6-495]). Comparative genomics through chemotaxonomic, DNA-DNA hybridization, and 16S rRNA sequencing approaches should be further evaluated occasionally through advanced computational technologies for establishing the evolutionary relationship among strains.

In this review, based on the NCBI database, we selected and analyzed the 16S rRNA gene in 51 representative worldwide strains of streptococcus species (*S. parauberis, S. iniae, S. agalactiae, L. garvieae, S. dysgalactiae,* and *V. salmoninarum*) ([Table 3](#t3-molce-41-6-495){ref-type="table"} and [Supplementary Table 1](#s1-molce-41-6-495){ref-type="supplementary-material"}). Our phylogenetic analysis demonstrates the interrelation of various strains and suggests that the 16S rRNA gene can easily segregate various strains based on genetic variations ([Fig. 4](#f4-molce-41-6-495){ref-type="fig"} and [Supplementary Fig. 1](#s1-molce-41-6-495){ref-type="supplementary-material"}). The evolutionary history was inferred using the Neighbor-Joining method and MEGA7. Earlier studies of streptococci microevolution have transferred to knowledge about the therapeutic developments ([@b34-molce-41-6-495]). Although our phylogenetic dendrograms clarify strain diversity according to 16S rRNA, evaluating other genetic factors related to virulence or adaptation will further elucidate pathogenic and evolutionary mechanisms.

Fully developed fishery management systems according to current challenges (diagnosis, pathogenesis, and control mechanism) are required. Understanding fish management at the local level is useful for the aquaculture industry ([@b6-molce-41-6-495]). We therefore suggest an effective aquaculture management module that utilizes a scientific approach to reconcile complex data of various cellular, molecular, and environmental approaches, and monitoring programs generated through research surveys.

Our study has important implications for the epidemiology of streptococcosis in fish, provides important information about the current scenario and challenges in the fish industry, and suggests joint molecular (for diagnosis) and cellular (for control) strategies along with environmental control methods as appropriate ([Tables 1](#t1-molce-41-6-495){ref-type="table"}, [2](#t2-molce-41-6-495){ref-type="table"} and [Figs. 1](#f1-molce-41-6-495){ref-type="fig"}[](#f2-molce-41-6-495){ref-type="fig"}[](#f3-molce-41-6-495){ref-type="fig"}--[4](#f4-molce-41-6-495){ref-type="fig"}). The above integrated strategies should focus on a worldwide sampling network for appropriate evolutionary monitoring through comparative genomics, then combine this information with ongoing aquaculture management systems.

CONCLUSION AND FUTURE PROSPECTS
===============================

Streptococcal infectious diseases, along with complicated control mechanisms, have contributed to a considerable decrease in fish production. This review highlights the current status of *Streptococcus* bacterial diagnosis, pathogenesis, hazardous effects of the host fish, and the overall negative economic impacts on the fish industry. In the absence of extensive knowledge about virulence, new emerging strains, treatments, and control of streptococcal disease, streptococcosis is becoming difficult to control. Based on the information presented in this review, we recommend early diagnosis using molecular methods and improved cellular research along with environmental control through appropriate managerial decisions considering the present scenario.

Supplementary data
==================

This research was a part of the project titled "Omics based on fishery disease control technology development and industrialization (20150242)", funded by the Ministry of Oceans and Fisheries, Korea. Anshuman Mishra would like to acknowledge PRF in Varanasi, India.

Note: [Supplementary information](#s1-molce-41-6-495){ref-type="supplementary-material"} is available on the Molecules and Cells website ([www.molcells.org](www.molcells.org)).

![Phylogeography of major fish pathogens belonging to *Streptococcus* species, *S. iniae* (red circle), *S. parauberis* (blue square), *S. dysgalactiae* (brown inverted box), *S. agalactiae* (orange star), *Lactococcus garvieae* (green plus sign), *Vagococcus salmoninarum* (yellow triangle), and *Lactococcus piscium* (violet rising sun). Distribution pattern shows the presence of these bacterial isolates over the continents](molce-41-6-495f1){#f1-molce-41-6-495}

![Schematic diagrams of diagnosis, control, and present challenges of Streptococcus disease. Bottom of the diagram shows the effect of these challenges](molce-41-6-495f2){#f2-molce-41-6-495}

![Schematic diagram of effective control strategy of *Streptococcus* infection in fish](molce-41-6-495f3){#f3-molce-41-6-495}

![Phylogenetic analysis of total 51 bacterial strains of Streptococcus species (*S. parauberis, S. iniae, S. agalactiae, Lactococcus garvieae, S. dysgalactiae, and Vagococcus salmoninarum*) causing streptococcal diseases based on 16S rDNA sequences from the NCBI database\
The evolutionary history was inferred using the Neighbor-Joining method. The optimal tree with the sum of branch length = 0.54759876 is shown. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (100 replicates) is shown next to the branches.](molce-41-6-495f4){#f4-molce-41-6-495}

###### 

Streptococcus bacterial agents and detailed information of affected fish species, locations, hosts, and clinical criteria

  Species                        Host                                                                               Fish species                                                                                                                                                                     Clinical Criteria                                                                                                                                                                        Geographical Location
  ------------------------------ ---------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------
  *Streptococcus iniae*          Fish, Human                                                                        Hybrid striped bass, Nile tilapia, Hybrid tilapia, Rainbow trout, Red drum, Rabbitfish, Sea bass, Olive flounder, Barramundi, Wild fish                                          Hemorrhage, exophthalmia, abdominal distension, ascites, lesions (liver, kidney, spleen, and intestine)                                                                                  Canada, Americas, Bahrain, Israel, Thailand, China, Japan, Singapore, Taiwan, Korea
  *Streptococcus parauberis*     Fish, Cow                                                                          Olive flounder, Rainbow trout, Cultured turbot, Hybrid striped bass                                                                                                              Chronic wasting syndrome, hemorrhagic septicemia, exophthalmia, meningitis with abnormal swimming                                                                                        Israel, Italy, Japan, Spain, USA, China, Iran, Korea, Malaysia, India
  *Streptococcus agalactiae*     Fish, Cow, Human, Chickens, Camels, Dogs, Horses, Cats, Frogs, Hamsters, Monkeys   Nile tilapia, Barcoo grunter, Golden pompano, Giant Queensland grouper, Ya-fish, Silver pomfret                                                                                  Erratic swimming, appetite, lethargy, uncoordinated movements, exophthalmia (uni- or bi-lateral), intraocular hemorrhage, opaqueness of cornea, ascites                                  Europe, Turkey, China, Indonesia, Malaysia, Japan, Korea, Vietnam, Philippines, Americas
  *Lactococcus garvieae*         Fish, Cow, Human, Cat, Dog, Water buffalo                                          Rainbow trout, Yellowtail, Tilapia, Japanese eel, Grey mullet, Black rockfish, Catfish, Wild wrasse, Giant fresh water prawn, Olive flounder, Amberjack, kingfish                Melanosis, lethargy, erratic swimming, disorientation, fins, exophthalmia (uni- or bi-lateral), swollen abdomens, anal prolapses, hemorrhages (periorbital, perianal, buccal regions)    Turkey, Australia, South Africa, England, Portugal France, Balkans, Israel, Korea
  *Streptococcus dysgalactiae*   Fish, Calves, Lamb, Human, Sheep, Dogs, Pig, Lamb, Cats                            White spotted snapper, Kingfish, Grey mullet, Cobia, Hybrid red tilapia, Pompano, Basket mullet, Pompano, Golden pomfret, Amur sturgeon, Nile tilapia, Yellow tail, Amber-jack   Abnormal swimming, loss of orientation, exophthalmia                                                                                                                                     Brazil, Indonesia, Malaysia, Taiwan, China, Japan
  *Vagococcus salmoninarum*      Fish                                                                               Rainbow trout, Atlantic salmon, Brown trout                                                                                                                                      Loss of equilibrium, exophthalmia, melanosis, bleeding (jaw, eye, mouth, abdomen, fins, and anus), necropsy, transparent fluid accumulation, fibrinous deposits (heart, liver, spleen)   France, Italy, Spain

###### 

Candidate genes used for differentiation and diagnosis of various Streptococcus bacterial agents

  Candidate gene                                           References
  -------------------------------------------------------- ------------------------------------------
  Manganese-dependent superoxide dismutase gene (*sodA)*   Kitten et al., 2012; Poyart et al., 2000
  Heat shock protein (*groESL)*                            Hung et al., 2013; Teng et al., 2014
  Ribosomal protein (*rpoB)*                               Drancourt et al., 2013
  Recombination and repair protein (*recN*)                Hung et al., 2013
  Repair protein *recN*                                    Glazunova et al., 2013
  Lactate oxidase gene (*lctO*)                            Zlotkin et al., 1998
  rRNA                                                     Clarridge et al., 2002
  RNA polymerase                                           Drancourt et al., 2004
  D-alanine-D-alanine ligase                               Garnier et al., 1997
  *b*-subunit of the elongation factor                     Picard et al., 2004
  Polysaccharide capsules gene (*cps*)                     [@b44-molce-41-6-495]
  Invasion associated gene (*iag*)                         [@b58-molce-41-6-495]
  Surface immunogenic protein (*sip*)                      [@b66-molce-41-6-495]
  C5a peptidase (*scp*)                                    [@b66-molce-41-6-495]
  Serine protease (*csp*)                                  [@b66-molce-41-6-495]
  tRNA gene intergenic spacer region (ITS)                 [@b69-molce-41-6-495]

###### 

Epidemiological specification (accession number, strain, and geographical location) of Streptococcus bacterial agents based on 16S rRNA gene sequences from the NCBI database

  Species                        Accession number   Strain                 Geographical region/country
  ------------------------------ ------------------ ---------------------- -----------------------------
  *Streptococcus iniae*          DQ985468.1         CGX                    China
                                 KY781829.1         HNM-1                  China
                                 KJ162337.1         Ab130920               China
                                 KF815728.1         WZMH110819             China
                                 KF555592.1         NS1-2011               Thailand
                                 KC748467.1         FC0924                 China
                                 KM209199.1         SK10-S                 Indonesia
                                 AB593340.1         Feb-45                 Japan
  *Streptococcus parauberis*     AY942573.1         LMG 14376              Finland
                                 FJ009631.1         JJI51                  Korea
                                 JQ780604.1         partial sequence       Israel
                                 KC836715.1         RU37-6                 China
                                 AF284579.2         SAP 99                 Italy
                                 KP137361.1         F21                    Turkey
                                 KP137342.1         F57                    Turkey
                                 KP240952.1         CIFT MFB 10119(2)      India
                                 KC699192.1         CNM465_12              Spain
  *Streptococcus agalactiae*     LC071815.1         JCM 5671               Japan
                                 AB596948.1         JCM 5671               Japan
                                 DQ303183.1         ATCC 13813             Canada
                                 AB002479.1         ATCC 13813-NCTC 8181   Japan
                                 NR_117503.1        ATCC 13813             USA
                                 NR_115728.1        ATCC 13813             USA
                                 GU360730.1         ATCC 13813             Netherlands
                                 KT869025.1         SAG                    Malaysia
                                 KY635952.1         S29                    Brazil
                                 KY635949.1         S73                    Brazil
  *Streptococcus dysgalactiae*   AB002485.1         ATCC 43078             Japan
                                 AB002500.1         isolate L32            Japan
                                 AB002509.1         isolate L9             Japan
                                 NR_027517.1        ATCC 43078             USA
                                 DQ232540.1         CIP 105120             France
                                 JN639380.1         CCUG 7977A             Denmark
                                 JN639434.1         SK1333                 Denmark
                                 JN639432.1         CCUG 36637             Denmark
                                 JN639410.1         CCUG 48101             Denmark
                                 AB002484.1         ATCC 27957             Japan
                                 AY121361.1         ATCC 12394             China
                                 AF015928.1         ATCC 27957             USA
                                 AJ314611.1         AC-2074                Germany
                                 AJ314609.1         AC-2713                Germany
                                 AJ314610.1         AC-2832                Germany
  *Lactococcus garvieae*         LC145570.1         JCM 12256              Japan
                                 KF111340.1         TRF1                   USA
                                 HM536980.1         PW1537                 China
                                 KX671996.1         FJ6                    Iran
                                 KF849271.1         SI-IRI                 Iran
                                 AF352164.1         FLG4                   China
                                 KM659863.1         Fish 10/10 LKF         South Africa
  *Vagococcus salmoninarum*      AM490375.1         JIP 20-00              France
                                 AM490374.1         JIP 27-01(2)           France
